SARS-CoV-2 Nucleocapsid 抗体
-
- 抗原 See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) 抗体
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
适用
- SARS Coronavirus-2 (SARS-CoV-2)
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This SARS-CoV-2 Nucleocapsid antibody is un-conjugated
-
应用范围
- ELISA, Western Blotting (WB), Colloidal Gold Immunochromatography Assay (GICA)
- 纯化方法
- Protein A purified
- 纯度
- ≥95 % as determined by SDS-PAGE
- 免疫原
- 2019 nCOV N protein
- 克隆位点
- 3C6
- 亚型
- IgG1
- Top Product
- Discover our top product SARS-CoV-2 N Primary Antibody
-
-
- 应用备注
- ELISA: Use at an assay dependent concentration(Suggestions: Use a concentration of 0.1 - 1 μg/mL)
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- CB buffer,
- 注意事项
- Avoid repeated freeze / thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- 有效期
- 12 months
-
-
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
: "
-
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
-
- 抗原
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- 别名
- SARS-CoV-2 Nucleocapsid protein (SARS-CoV-2 N 产品)
- 别名
- nucleocapsid phosphoprotein antibody, N antibody
- 物质类
- Viral Protein
- 背景
- Synonyms: Background:
- 分子量
- 48 kDa
-